Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer
Abstract Up to 40% of luminal breast cancer patients carry activating mutations in the PIK3CA gene. PIK3CA mutations commonly co-occur with other mutations, but the implication of this co-occurrence may vary according to the specific genes involved. Here, we characterized a subgroup of luminal breas...
Main Authors: | Liat Anabel Sinberger, Tamar Zahavi, Amir Sonnenblick, Mali Salmon‐Divon |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-11-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-48002-x |
Similar Items
-
Alpelisib Efficacy in Hormone Receptor-Positive HER2-Negative PIK3CA-Mutant Advanced Breast Cancer Post-Everolimus Treatment
by: Ari Raphael, et al.
Published: (2022-09-01) -
Exploring potential biomarkers and therapeutic targets in inflammatory bowel disease: insights from a mega-analysis approach
by: Edia Stemmer, et al.
Published: (2024-03-01) -
Impact of the OncotypeDX score and HER2 RNA PCR levels on HER2-low IHC levels in primary and metastasized tumors
by: Didi Feldman, et al.
Published: (2023-10-01) -
The Acidic Stress Response of the Intracellular Pathogen <i>Brucella melitensis</i>: New Insights from a Comparative, Genome-Wide Transcriptome Analysis
by: David Kornspan, et al.
Published: (2020-08-01) -
Transcriptomic Analysis of the Brucella melitensis Rev.1 Vaccine Strain in an Acidic Environment: Insights Into Virulence Attenuation
by: Mali Salmon-Divon, et al.
Published: (2019-02-01)